BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17574613)

  • 1. Down-regulation of HLA class I antigens in prostate cancer tissues and up-regulation by histone deacetylase inhibition.
    Kitamura H; Torigoe T; Asanuma H; Honma I; Sato N; Tsukamoto T
    J Urol; 2007 Aug; 178(2):692-6. PubMed ID: 17574613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P; Schweyer S; Hemmerlein B; Wuttke W; Seseke F; Ringert RH
    Int J Oncol; 2004 Jan; 24(1):25-31. PubMed ID: 14654937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFI16 in human prostate cancer.
    Alimirah F; Chen J; Davis FJ; Choubey D
    Mol Cancer Res; 2007 Mar; 5(3):251-9. PubMed ID: 17339605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells.
    Frønsdal K; Saatcioglu F
    Prostate; 2005 Feb; 62(3):299-306. PubMed ID: 15389787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.
    Qian DZ; Wei YF; Wang X; Kato Y; Cheng L; Pili R
    Prostate; 2007 Aug; 67(11):1182-93. PubMed ID: 17520666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer.
    Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA
    Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells.
    Hernandez M; Shao Q; Yang XJ; Luh SP; Kandouz M; Batist G; Laird DW; Alaoui-Jamali MA
    Prostate; 2006 Aug; 66(11):1151-61. PubMed ID: 16652385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Histone Deacetylase Inhibitor (HDACi); Trichostatin-A (TSA) on the expression of housekeeping genes.
    Mogal A; Abdulkadir SA
    Mol Cell Probes; 2006 Apr; 20(2):81-6. PubMed ID: 16326072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition.
    Pellicciotta I; Cortez-Gonzalez X; Sasik R; Reiter Y; Hardiman G; Langlade-Demoyen P; Zanetti M
    Cancer Res; 2008 Oct; 68(19):8085-93. PubMed ID: 18829567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone deacetylase inhibitor trichostatin A downregulates human MDR1 (ABCB1) gene expression by a transcription-dependent mechanism in a drug-resistant small cell lung carcinoma cell line model.
    El-Khoury V; Breuzard G; Fourré N; Dufer J
    Br J Cancer; 2007 Aug; 97(4):562-73. PubMed ID: 17667922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Yoo J; Lee YJ
    Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic activation of alpha4, beta2 and beta6 integrins involved in cell migration in trichostatin A-treated Hep3B cells.
    Lin KT; Yeh SH; Chen DS; Chen PJ; Jou YS
    J Biomed Sci; 2005 Oct; 12(5):803-13. PubMed ID: 16132114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of locus-specific human lymphocyte antigen class I expression in Epstein-Barr virus-associated gastric cancer: implication for viral-induced immune evasion.
    Dutta N; Gupta A; Mazumder DN; Banerjee S
    Cancer; 2006 Apr; 106(8):1685-93. PubMed ID: 16541432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitor FR235222 sensitizes human prostate adenocarcinoma cells to apoptosis through up-regulation of Annexin A1.
    D'Acunto CW; Fontanella B; Rodriquez M; Taddei M; Parente L; Petrella A
    Cancer Lett; 2010 Sep; 295(1):85-91. PubMed ID: 20227822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation.
    Law AY; Lai KP; Lui WC; Wan HT; Wong CK
    Exp Cell Res; 2008 Oct; 314(16):2975-84. PubMed ID: 18652825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic mechanism of growth inhibition induced by phenylhexyl isothiocyanate in prostate cancer cells.
    Beklemisheva AA; Fang Y; Feng J; Ma X; Dai W; Chiao JW
    Anticancer Res; 2006; 26(2A):1225-30. PubMed ID: 16619528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy.
    Carlsson B; Forsberg O; Bengtsson M; Tötterman TH; Essand M
    Prostate; 2007 Mar; 67(4):389-95. PubMed ID: 17219382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.